SOA Wealth Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8K Buy
+21,280
New +$4M 0.01% 420
2026
Q1
Sell
-116
Closed -$21.3K 869
2025
Q4
$21.3K Sell
116
-59
-34% -$10.3K ﹤0.01% 495
2025
Q3
$26.8K Buy
175
+60
+52% +$9.08K ﹤0.01% 468
2025
Q2
$16.1K Hold
115
﹤0.01% 541
2025
Q1
$16.9K Buy
115
+1
+0.9% +$145 ﹤0.01% 497
2024
Q4
$14.9K Hold
114
﹤0.01% 500
2024
Q3
$17.7K Buy
114
+1
+0.9% +$161 ﹤0.01% 463
2024
Q2
$17.6K Sell
113
-1
-0.9% -$150 ﹤0.01% 458
2024
Q1
$15.4K Buy
114
+2
+2% +$265 ﹤0.01% 477
2023
Q4
$15.1K Hold
112
﹤0.01% 468
2023
Q3
$15.2K Hold
112
﹤0.01% 466
2023
Q2
$15.9K Hold
112
﹤0.01% 463
2023
Q1
$15.5K Buy
112
+2
+2% +$269 ﹤0.01% 472
2022
Q4
$14.9K Hold
110
﹤0.01% 458
2022
Q3
$12K Hold
110
﹤0.01% 475
2022
Q2
$14K Sell
110
-14
-11% -$1.84K ﹤0.01% 438
2022
Q1
$16K Buy
124
+2
+2% +$240 ﹤0.01% 501
2021
Q4
$14K Hold
122
﹤0.01% 508
2021
Q3
$14K Sell
122
-123
-50% -$14.3K ﹤0.01% 513
2021
Q2
$29K Sell
245
-76
-24% -$8.34K 0.01% 393
2021
Q1
$31K Sell
321
-69
-18% -$6.94K 0.01% 325
2020
Q4
$38K Buy
+390
New +$41.3K 0.01% 298

Other funds holding AZN

SOA Wealth Advisors's AZN Position: Q2 2026 in Review

SOA Wealth Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 21,280 shares worth $42.8K. The stake represents 0.01% of the portfolio and ranks #420 among its holdings. This is a return to the name: SOA Wealth Advisors previously reported a position in AZN as recently as Q4 2025.

SOA Wealth Advisors first reported a position in AZN in Q4 2020 and has held it in 22 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • SOA Wealth Advisors held 21,280 shares of AstraZeneca worth $42.8K as of Q2 2026.
  • AstraZeneca was a new SOA Wealth Advisors position in Q2 2026.
  • AstraZeneca made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #420 holding.
  • SOA Wealth Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 22 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.